The recent identification of mutations in genes encoding demonstrated or putative glycosyltransferases has revealed a novel mechanism for congenital muscular dystrophy. Hypoglycosylated alpha-dystroglycan (alpha-DG) is commonly seen in Fukuyama-type congenital muscular dystrophy (FCMD), muscle-eye-brain disease (MEB), Walker-Warburg syndrome (WWS), and Large(myd) mice. POMGnT1 and POMTs, the gene products responsible for MEB and WWS, respectively, synthesize unique O-mannose sugar chains on alpha-DG. The function of fukutin, the gene product responsible for FCMD, remains undetermined. Here we show that fukutin co-localizes with POMGnT1 in the Golgi apparatus. Direct interaction between fukutin and POMGnT1 was confirmed by co-immunoprecipitation and two-hybrid analyses. The transmembrane region of fukutin mediates its localization to the Golgi and participates in the interaction with POMGnT1. Y371C, a missense mutation found in FCMD, retains fukutin in the ER and also redirects POMGnT1 to the ER. Finally, we demonstrate reduced POMGnT1 enzymatic activity in transgenic knock-in mice carrying the retrotransposal insertion in the fukutin gene, the prevalent mutation in FCMD. From these findings, we propose that fukutin forms a complex with POMGnT1 and may modulate its enzymatic activity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2006.09.129DOI Listing

Publication Analysis

Top Keywords

fukutin
8
interaction fukutin
8
pomgnt1
8
fukutin pomgnt1
8
congenital muscular
8
muscular dystrophy
8
fukutin gene
8
mutation fcmd
8
enzymatic activity
8
molecular interaction
4

Similar Publications

Objective: Limb-girdle muscular dystrophy R9 (LGMDR9, formerly known as LGMD2I), caused by variants in the fukutin-related protein (FKRP) gene leads to progressive muscle weakness of the shoulder and pelvic limb-girdles and loss of motor function over time. Clinical management and future trial design are improved by determining which standardized clinical outcome assessments (COA) of function are most appropriate to capture disease presentation and progression, informing endpoint selection and enrollment criteria. The purpose of our study was to evaluate the cross-sectional validity and reliability of clinical outcome assessments in patients with FKRP-related LGMDR9 participating in the Genetic Resolution and Assessments Solving Phenotypes in LGMD (GRASP) natural history study.

View Article and Find Full Text PDF
Article Synopsis
  • Pathogenic variants in the FKRP gene cause various muscular dystrophies, including Limb-Girdle Muscular Dystrophy type 9 (LGMDR9), which is notably prevalent in Italy.
  • A study analyzed 153 patients from Southern Italy showing Duchenne/Becker-like symptoms, identifying pathogenic variants in 16 individuals, with specific variants frequently found.
  • The findings emphasize the need to include LGMDR9 in the diagnosis of dystrophinopathies, aiming to improve the identification and management of affected patients in Calabria.
View Article and Find Full Text PDF

Clinical and genetic evaluation of hereditary myopathies in an adult Saudi cohort.

BMC Neurol

September 2024

Department of Internal Medicine, College of Medicine, King Saud University, PO Box 7805, Riyadh, 11472, Saudi Arabia.

Article Synopsis
  • * Out of 87 patients, limb-girdle muscular dystrophy (LGMD) was the most common diagnosis, with 68% of tested patients achieving a genetic diagnosis, primarily identifying dysferlinopathy and FKRP-related disorders.
  • * The study emphasizes the importance of various molecular genetic testing methods, particularly noting their success rates, and advocates for better access to advanced testing for conditions like FSHD and mitochondrial myopathies.
View Article and Find Full Text PDF

Rat animal models are widely used owing to their relatively superior cognitive abilities and higher similarity compared with mouse models to human physiological characteristics. However, their use is limited because of difficulties in establishing embryonic stem cells and performing genetic modifications, and insufficient embryological research. In this study, we established optimal superovulation and fertilized-egg transfer conditions, including optimal hormone injection concentration (≥150 IU/kg of PMSG and hCG) and culture medium (mR1ECM), to obtain high-quality zygotes and establish in vitro fertilization conditions for rats.

View Article and Find Full Text PDF
Article Synopsis
  • Three types of muscular dystrophy, called dystroglycanopathies, are linked to problems in the ribitol pathway and involve specific gene mutations.
  • Ribose supplementation was tested in a patient with limb girdle muscular dystrophy type 2I, showing it was well tolerated and led to significant increases in a beneficial compound (CDP-ribitol) and a decrease in muscle enzyme levels.
  • Although the clinical and patient-reported outcomes didn't show objective improvements, the patient felt subjective benefits in muscle strength, fatigue, and pain, suggesting more research is needed on ribose's effects.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!